| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.09 | 0.3 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |